This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Universitè Laval. Active years: 1997-2019.
Company Filing History:
Years Active: 1997-2019
Title: Louis Lafleur: Innovator in Light Modulation and Chimeric Cell Cultures
Introduction
Louis Lafleur is a notable inventor based in Canada, recognized for his contributions to the fields of artificial light systems and regenerative medicine. With a total of 2 patents, Lafleur has made significant strides in enhancing human health and well-being through innovative technologies.
Latest Patents
Lafleur's latest patents include an "Apparatus and method for influencing a condition in a subject." This invention focuses on an artificial light system designed to modulate circadian rhythms, increase vigilance, and influence light-associated psychological conditions such as seasonal affective disorder. The system utilizes a combination of green and/or red light and blue light, both controlled by a computer to provide predetermined light conditions. The computer is programmed to deliver pulses of blue light alongside continuous or pulsed red light, enhancing the efficacy of blue light while minimizing potential hazards.
Another significant patent is for "Chimeric sheets of epithelial cells." This process involves culturing and generating a chimeric cell culture, particularly chimeric epithelium, which can be utilized to treat skin trauma, such as in burn victims. The chimeric epithelium comprises both autologous and allogeneic cells, allowing for a more efficient treatment process. This innovation significantly reduces the time required for autologous cell expansion and culture prior to grafting, demonstrating a promising advancement in regenerative medicine.
Career Highlights
Louis Lafleur is affiliated with Université Laval, where he continues to contribute to research and development in his areas of expertise. His work has garnered attention for its potential applications in both psychological health and medical treatments.
Collaborations
Lafleur has collaborated with notable colleagues, including Marc Hébert and Francedillaois A Auger, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Louis Lafleur stands out as an innovative inventor whose work in light modulation and chimeric cell cultures has the potential to transform health care practices. His patents reflect a commitment to improving human health through scientific advancements.